Lucigen to use TriLink CleanAmp for DNA amplification
TriLink BioTechnologies and Lucigen Corporation has signed a licensing agreement under which Lucigen will use TriLink's CleanAmp dNTPs in its new Taq98 Hot Start 2X MasterMix to amplify difficult DNA templates.
Lucigen's new Taq98 Hot Start 2X Master Mix amplifies difficult DNA templates, including targets with >70% GC content.
By replacing the Lucigen's dNTPs in a PCR assay with CleanAmp dNTPs, a Hot Start reaction will be achieved.
The approach to new PCR provides a method to reduce mis-priming, primer dimer formation and other deleterious off-target effects in PCR.
Lucigen president Jeff Williams said the company has found that CleanAmp dNTPs improve the performance of a number of thermostable DNA polymerases, allowing for simple conversion of any assay to a Hot Start version.
Related Insight
Suppliers Directory
Diagnostics In Vitro Diagnostics Diagnostic Imaging Endoscopy Devices
Patient Care Patient Monitoring Surgical & Supplies Wound Care Management
Technology Automation Healthcare IT Packaging
Contract Services
Certification
In Vitro Diagnostics Intelligence
GlobalData’s new report, “External Defibrillators - Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2016” provides key data, information and analysis on the global external defibrillators market. The report provides market landscape, competitive landscape and market trends information the external defibrillators market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts. Buy online from $3500
Comments may be moderated for spam, obscenities or defamation.